2 Sources
+3 3 0
Published 9 years ago by trails with 0 Comments
by trails
9 years ago

Roche’s Ocrelizumab Found to be Superior to Standard Interferon Therapy in Relapsing Multiple Sclerosis Patients

Read about How Roche’s Ocrelizumab Found to be Superior to Standard Interferon Therapy in Relapsing Multiple Sclerosis Patients.

Continue Reading http://multiplesclerosisnewstoday.com

Join the Discussion

  • Auto Tier
  • All
  • 1
  • 2
  • 3
Post Comment

Here are some other snaps you may like...

discover your
interests.

Check out our front page for a lot more stuff!

Novartis' Gilenya Found to Have Long-Term Positive Effects on Patients with Relapsing-Remitting Multiple Sclerosis

Multiple Sclerosis Research: Listeria with Alemtuzumab - 2 cases reported

FDA Approves Bayer's Electronic Autoinjector for MS Therapy

Altered Immune Cells in Relapsing Remitting Multiple Sclerosis Patients Cause Reduced Immune Capacity

Multiple Sclerosis Research: Bye Bye Yuti